18
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T28865 | STAT3-IN-B9 | STAT3 IN B9,B9 | STAT |
STAT3-IN-B9 (B9) is an inhibitor of abnormal STAT3 activation and inhibits the proliferation of tumor cells including MDA-MB-468, MDA-MB-231, and DU145. | |||
T0062 | Folic acid | Folate,Vitamin B9,Pteroylglutamic acid,Vitamin M,Folacin | DNA/RNA Synthesis , Endogenous Metabolite |
Folic acid (Vitamin B9)(Vitamin M; Vitamin B9) is indispensable for the production and maintenance of new cells, for DNA/RNA synthesis. | |||
T82579 | Dermaseptin-B9 | ||
Dermaseptin-B9, an antimicrobial peptide, has been isolated from the Phyllomedusinae subfamily of frogs [1]. | |||
T13112L1 | Tat-NR2B9c acetate | Tat-NR2B9c acetate (500992-11-0 Free base),NA-1 acetate | Others |
Tat-NR2B9c acetate (NA-1 acetate) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c acetate disrupts the PSD-... | |||
T13112 | Tat-NR2B9c | Tat-NR2Bct,NA-1 | NO Synthase , iGluR |
Tat-NR2B9c (NA-1) is a postsynaptic density-95 (PSD-95) inhibitor with neuroprotective and antiepileptic effects.Tat-NR2B9c inhibits PSD-95d2, PSD-95d1, and PSD-95, which prevents the activation of NMDA-induced NADPH oxi... | |||
TQ0009 | UCB9608 | PI4K | |
UCB9608 is a selective and orally active PI4KIIIβ inhibitor (IC50: 11 nM), selective over PI3KC2 α, β, and γ lipid kinases. | |||
T8646 | URB937 | FAAH | |
URB937 is an inhibitor of FAAH and increases anandamide levels(IC50 : 26.8 nM). | |||
T14078 | AB928 | Adenosine Receptor | |
AB928 is an orally bioavailable, selective dual adenosine receptor (A2aR/A2bR) antagonist. It has immunomodulatory activity[1]. | |||
T13112L | Tat-NR2B9c TFA | NA-1 (TFA) | Others |
Tat-NR2B9c TFA is a 20-aa peptide, and acts as an inhibitor of postsynaptic density-95 (PSD-95)(EC50 of 6.7 nM for PSD-95d2), and possesses neuroprotective efficacy. | |||
T22343 | HKB99 | Others | |
HKB99, an allosteric inhibitor of phosphoglycerate mutase 1, could suppresse tumor growth and metastasis and overcome erlotinib resistance in non-small-cell lung cancer (NSCLC) | |||
T31569 | DP-b99 | DP-b-99,DP-BAPTA-99,DPb-99,DPBAPTA-99,DP-b 99 | |
DP-B 99 (DP-B 99, DP-BAPTA-99, DPB-99, DP-BAPTA-99) is a potential chelating agent for the treatment of acute pancreatitis. | |||
T77806 | KRAS inhibitor FB9 | ||
KRAS inhibitor FB9 can be used in studies about Ras. | |||
T81037 | Tat-HA-NR2B9c | ||
Tat-HA-NR2B9, comprising an HIV-1 Tat transduction domain fragment, an influenza virus hemagglutinin (HA) epitope-tag, and the C-terminal 9 amino acids of NR2B (NR2B9c), has demonstrated efficacy in reducing infarct size... | |||
T15484 | HJB97 | Epigenetic Reader Domain | |
HJB97 is used for the design of potential PROTAC BET degrader. It also has antitumor activity. HJB97 is a high-affinity inhibitor of BET (Kis: 0.9 nM (BRD2 BD1), 0.27 nM (BRD2 BD2), 0.18 nM (BRD3 BD1), 0.21 nM (BRD3 BD2... | |||
T21367 | Tetrahydrofolic acid | 5,6,7,8-tetrahydrofolic acid,folate-H4,Tetrahydropteroylglutamic acid,th-folate | Endogenous Metabolite |
Tetrahydrofolic acid (5,6,7,8-tetrahydrofolic acid) is a vitamin B9 derivative that is a common one-carbon donor in organisms and is involved in growth and metabolism. | |||
T32075 | HH-Folic acid | ||
HH-Folic acid derives from vitamin B9. | |||
T78930 | T3SS-IN-1 | ||
T3SS-IN-1 (compound B9) is a potent type III secretion system (T3SS) inhibitor that also suppresses hpa1 promoter activity and harpin protein expression, without impacting bacterial growth [1]. | |||
T32705 | Levomefolate magnesium | L-Methylfolate magnesium | |
Levomefolate magnesium is the magnesium salt of the metabolite of folic acid (Vitamin B9) and it is a predominant active form of folate found in foods and in the blood circulation, accounting for 98% of folates in human ... |